247 related articles for article (PubMed ID: 11743050)
21. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells.
Hanamoto H; Nakayama T; Miyazato H; Takegawa S; Hieshima K; Tatsumi Y; Kanamaru A; Yoshie O
Am J Pathol; 2004 Mar; 164(3):997-1006. PubMed ID: 14982853
[TBL] [Abstract][Full Text] [Related]
22. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
[TBL] [Abstract][Full Text] [Related]
23. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1978 May; 125(1):39-51. PubMed ID: 569193
[TBL] [Abstract][Full Text] [Related]
25. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
26. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
27. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
Basu D; Roy SK
Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis.
Shimizu K; Karube K; Arakawa F; Nomura Y; Komatani H; Yamamoto K; Yoshida S; Aoki R; Sugita Y; Takeshita M; Ohshima K
Cancer Sci; 2007 Dec; 98(12):1875-80. PubMed ID: 17900259
[TBL] [Abstract][Full Text] [Related]
29. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
30. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia.
Teruya-Feldstein J; Jaffe ES; Burd PR; Kingma DW; Setsuda JE; Tosato G
Blood; 1999 Apr; 93(8):2463-70. PubMed ID: 10194423
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
[TBL] [Abstract][Full Text] [Related]
32. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
[TBL] [Abstract][Full Text] [Related]
33. Macrophage-derived chemokine gene expression in human and macaque cells: mRNA quantification using NASBA technology.
Romano JW; Shurtliff RN; Grace M; Lee EM; Ginocchio C; Kaplan M; Pal R
Cytokine; 2001 Mar; 13(6):325-33. PubMed ID: 11292315
[TBL] [Abstract][Full Text] [Related]
34. Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer.
Nakanishi T; Imaizumi K; Hasegawa Y; Kawabe T; Hashimoto N; Okamoto M; Shimokata K
Cancer Immunol Immunother; 2006 Nov; 55(11):1320-9. PubMed ID: 16453150
[TBL] [Abstract][Full Text] [Related]
35. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
Chen XQ; Wang WL; Huang GS
Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
37. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
38. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.
Foss HD; Hummel M; Gottstein S; Ziemann K; Falini B; Herbst H; Stein H
Am J Pathol; 1995 Jan; 146(1):33-9. PubMed ID: 7856736
[TBL] [Abstract][Full Text] [Related]
39. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
40. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
